Opinion: Supreme Court vaccine rulings hold more questions than answers for employers
By Ryan Haws On Jan. 13, as COVID-19 cases across the nation surged to seemingly omnipresent levels, a divided United States Supreme Court issued two key orders affecting President Joe Biden’s “Path Out of the Pandemic” action plan. The first order belatedly held that the Occupational Safety and Health Administration exceeded its authority with its Read More →
Opinion: Top 10 pandemic hopes for 2022
By Ritch Eich Pandemic fatigue is a real thing. I’m tired of the pandemic, you’re tired of the pandemic, people the world over are tired of the pandemic. But COVID-19 continues to harass us, and no one knows when the pandemic will end. In the meantime, let’s do what we can to make life better, Read More →
Women continue to bear economic brunt of pandemic, especially in California
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
In this COVID wave, businesses must make their own public health decisions
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen shares drop despite projected revenue growth
Goleta-based Inogen expects minor revenue growth in the fourth quarter of 2021 but major growth for the full fiscal year, according to preliminary estimates the company released Jan. 10. The portable oxygen concentrator manufacturer expects to see revenue in the range of $75.9 million to $76.9 million for the three months ended December 31, growth Read More →
Sientra shares up after company releases 2021 revenue estimates
The Goleta-based breast implant manufacturer Sientra expects growth in the fourth quarter of 2021 and estimates its “highest-ever breast products yearly revenue” of up to $81 million for the full year, the company said Jan. 10. Sientra reported that its preliminary unaudited revenue from operations for the fourth quarter of 2021 is expected to be Read More →
Amgen inks drug development deal worth up to $1.9B
Thousand Oaks-based Amgen has reached an agreement with Generate Biomedicines, a Massachusetts-based therapeutics company, to research, discover and create protein therapeutics, the company announced Jan. 6. According to the agreement, Amgen, one of the largest biotech companies in the world, will pay $50 million up front to fund the initial five programs, with a potential Read More →
